Summary
ASCO19 summary; Protac – ARV-110; PARP-I’s for PCa & TOPARP-b trial results; Axumin vs other scans … and when to scan; Intermittent Hormone Therapy experience; primary vs distant tumor composition; how often should advanced disease men get their PSA tested; anti-angiogenic drugs for PCa; possible new source for biopsy 2nd opinions
Note: For more information on ASCO19, please search this blog.
For any follow-up questions or additional links, e-mail info@ancan.org